The latest prostate cancer news
Testosterone slows prostate cancer recurrence in low-risk patients
In the largest such study so far undertaken, US researchers have shown that testosterone replacement…
Browsing: Prostate Cancer
Mental health state associated with higher death rates for prostate and urological cancers
Patients with prostate, bladder or kidney cancers are at greater risk of dying if they…
Hormonal treatment may trigger depression in men with prostate cancer
Men who receive anti-hormonal treatment after having their prostate removed are 80% more likely to…
Doctors need to talk through treatment options better for black men with prostate cancer
Rajesh Balkrishnan, University of Virginia and Randy A. Jones, University of Virginia African-American men have…
Study suggests personality tests may improve care for prostate cancer patients
Scientists have found that men with high neuroticism—between a quarter and a fifth of men…
Prostate cancer patients believe robotic surgery is superior – despite limited evidence
An Australian-first study by a team at UNSW Medicine, the Ingham Institute and South Western…
Hypofractionated radiotherapy should be considered new practice standard for men with low-risk prostate cancer
Results from a clinical study (NRG-RTOG 0415) determined that a hypofractionated radiotherapy schedule (H-RT), a…
ASCO GU 2019: Phase II Trial Shows Novel, Radiolabeled PSMA-Targeted Treatment Provides High Response Rates in Men With Metastatic Prostate Cancer
A single-arm, phase II trial in men with PSMA-positive metastatic, castration-resistant prostate cancer (mCRPC) that…
ASCO GU 2019: Preliminary results from a phase II GALAHAD study in adults with metastatic castration-resistant prostate cancer and DNA repair pathway defects
This study evaluated niraparib, which is a poly (ADP-ribose) polymerase (PARP) inhibitor, in patients with metastatic…
ASCO GU 2019: Immunotherapy combination generates responses against castration-resistant metastatic prostate cancer
Some patients with metastatic prostate cancer respond to a combination of immune checkpoint inhibitors after…